*Yasuhiro Funahashi^1,2, Rijwan Uddin Ahammad ^1,2, Xinjian Zhang3³, Emran Hossen^1,2, Masahiro Kawatani⁴, Akira Yoshimi^6,7, Minhua Wu⁶, Huanhuan Wang^1,3, Xu Li^1,2, Daisuke Tsuboi^1,2, Tomoki Nishioka^1,2, Keisuke Kuroda⁵, Mutsuki Amano⁵, Yukihiko Noda^6,7, Kiyofumi Yamada⁶, Kenji Sakimura⁸, Taku Nagai³, Takayuki Yamashita⁴, Shigeo Uchino⁹, Kozo Kaibuchi^1,2 (1. CMS, Fujita Health Univ, Aichi, Japan, 2. Div Cell Biol, ICBS, Fujita Health Univ, Aichi, Japan, 3. Div Behav Neuropharmacol, ICBS, Fujita Health Univ, Aichi, Japan, 4. Dept Physiol, Sch Med, Fujita Health Univ, Aichi, Japan, 5. Dept Cell Pharmacol, Grad Sch Med, Nagoya Univ, Aichi, Japan, 6. Dept Neuropsychopharmacol Hospital Pharm, Grad Sch Med, Nagoya Univ, Aichi, Japan, 7. Div Clin Sci Neuropsychopharmacol, Fac Grad Sch Pharm, Meijo Univ, Aichi, Japan, 8. Brain Res Inst, Niigata Univ, Niigata, Japan, 9. Dept Biosci, Sch Sci Eng, Teikyo Univ, Tochigi, Japan)

*Birkan Girgin¹, Fumito Naganuma¹, Anne Bernadette Agu¹, Tadaho Nakamura², Takatoshi Mochizuki³, Takeo Yoshikawa¹ (1. Department of Neuropharmacology, Hokkaido University Graduate School of Medicine, 2. Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 3. International Institute for Integrative Sleep Medicine (WPI-IIIS), University of Tsukuba)